Home Newsletters Cell Therapy News A Novel TanCAR Targeting IL13Rα2 and EphA2 for Enhanced Glioblastoma Therapy

A Novel TanCAR Targeting IL13Rα2 and EphA2 for Enhanced Glioblastoma Therapy

0
To improve CAR-T therapy for glioblastoma, a new TanCAR, comprising the tandem arrangement of IL13 and EphA2 scFv, was generated and validated in vitro and in vivo.
[Molecular Therapy-Oncolytics]

Sorry, but the selected Zotpress account can't be found.

AbstractFull ArticleGraphical Abstract
Exit mobile version